[144] Nuvation Bio Inc. SEC Filing

Rhea-AI Filing Summary

A shareholder of NUVB has filed a Rule 144 notice to sell up to 369,051 common shares through broker Morgan Stanley Smith Barney LLC on the NYSE. The filing lists an aggregate market value of 2,667,131.58 for these shares, compared with 342,833,433 common shares outstanding. The shares come from the exercise of stock options under a registered plan, with lots of 300,000 and 69,051 options exercised for cash on 11/20/2025. The notice also discloses that Gary Hattersley sold 100,000 common shares for gross proceeds of 502,460.00 on 10/27/2025 during the prior three months.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	369051	2667131.58	342833433	11/20/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/20/2025	Exercise of options under a registered plan	Issuer			300000	11/20/2025	Cash
Common	11/20/2025	Exercise of options under a registered plan	Issuer			69051	11/20/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Hattersley Gary 1500 Broadway Suite 1401 New York NY 10036	Common	10/27/2025	100000	502460.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the NUVB Form 144 filing disclose?

The Form 144 for NUVB discloses a shareholder’s intent to sell up to 369,051 common shares under Rule 144, using Morgan Stanley Smith Barney LLC as broker on the NYSE.

How many NUVB shares are proposed to be sold and what is their market value?

The notice covers up to 369,051 common shares of NUVB with an aggregate market value of 2,667,131.58 as stated in the filing.

How were the NUVB shares in this Form 144 acquired?

The shares were acquired through the exercise of stock options under a registered plan, with 300,000 and 69,051 options exercised for cash on 11/20/2025.

What is the total number of NUVB shares outstanding mentioned in the filing?

The filing states that 342,833,433 common shares of NUVB were outstanding at the time referenced.

Which broker and exchange are involved in the planned NUVB share sale?

The planned sale of NUVB shares is through Morgan Stanley Smith Barney LLC Executive Financial Services, with trading on the NYSE.

Were there any recent NUVB share sales by the same person before this notice?

Yes. During the past three months, Gary Hattersley sold 100,000 NUVB common shares on 10/27/2025 for gross proceeds of 502,460.00.

What representation does the seller make about NUVB’s information in this Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about NUVB that has not been publicly disclosed.